CN101450166A - Traditional Chinese medicine composition with blood-sugar function and preparation method thereof - Google Patents
Traditional Chinese medicine composition with blood-sugar function and preparation method thereof Download PDFInfo
- Publication number
- CN101450166A CN101450166A CNA2007101785076A CN200710178507A CN101450166A CN 101450166 A CN101450166 A CN 101450166A CN A2007101785076 A CNA2007101785076 A CN A2007101785076A CN 200710178507 A CN200710178507 A CN 200710178507A CN 101450166 A CN101450166 A CN 101450166A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- fructus momordicae
- preparation
- folium mori
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 17
- 230000002218 hypoglycaemic effect Effects 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 18
- 238000001035 drying Methods 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 239000000469 ethanolic extract Substances 0.000 claims description 3
- 235000013402 health food Nutrition 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 2
- 244000302512 Momordica charantia Species 0.000 abstract 1
- 235000009811 Momordica charantia Nutrition 0.000 abstract 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 abstract 1
- 235000018365 Momordica dioica Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 12
- 239000008187 granular material Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 9
- 229960004756 ethanol Drugs 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- 238000002481 ethanol extraction Methods 0.000 description 7
- 201000001421 hyperglycemia Diseases 0.000 description 7
- 210000000582 semen Anatomy 0.000 description 7
- 238000005303 weighing Methods 0.000 description 7
- 239000002775 capsule Substances 0.000 description 6
- 239000000945 filler Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- -1 antiseptic Substances 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 229940023488 pill Drugs 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000007919 dispersible tablet Substances 0.000 description 3
- 239000007938 effervescent tablet Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229940046011 buccal tablet Drugs 0.000 description 2
- 239000006189 buccal tablet Substances 0.000 description 2
- 229930185803 charantin Natural products 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000007910 chewable tablet Substances 0.000 description 2
- 229940068682 chewable tablet Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition with hypoglycemic function and preparation method thereof. The traditional Chinese medicine is made from balsam pear, mulberry leaf and polyghace seche according to a certain weight proportion; and it can be made into any common oral taken preparation form. The Chinese traditional medicine composition in the invention achieves hypoglycemic function, and can be used to treat diabetes.
Description
Technical field
The wood invention relates to a kind of Chinese medicine composition with function of blood sugar reduction and preparation method thereof, belongs to Chinese medicine and field of health care food.
Background technology
Diabetes are the one group of Developmental and Metabolic Disorder syndromes that is caused by the h and E factor interaction.Long-term diabetes can cause the chronic complicating diseases of a plurality of systems organ, cause dysfunction and depletion, become disable, lethal main cause.At present, the prevalence of diabetes had the trend of remarkable rising in recent years in the population of China.Because the cause of disease and the pathogenesis of diabetes are not clear fully as yet, therefore also lack effective etiological treatment method at present.Clinically treatment of diabetes is adopted insulinize and oral hypoglycemic drug therapy more now, yet diabetes spp is in a kind of lifelong participation disease, need long-term prescription, the drug administration by injection method of insulin tends to bring many inconvenience to the patient, and clinical orally-taken blood sugar reducing medicine commonly used belongs to chemical drugs more, takes for a long time also and can cause a series of untoward reaction.In view of there being above problem, so exploitation a kind of blood sugar lowering Chinese medicine and health food safe, effective, that be suitable for taking for a long time are badly in need of on present market very much.
Summary of the invention
The object of the invention just provides a kind of Chinese medicine composition with function of blood sugar reduction.
Another object of the present invention has provided the preparation method of this Chinese medicine composition.
The present invention is achieved by the following technical solutions:
The present invention is made by the following weight proportion raw material:
Fructus Momordicae charantiae 10-30 part, Folium Mori 5-9 part and Rhizoma Polygonati Odorati 6-12 part.
Be preferably:
9 parts of 15 parts in Fructus Momordicae charantiae, 7 parts on Folium Mori and Rhizoma Polygonati Odorati.
The preparation method of Chinese medicine composition of the present invention is as follows:
Fructus Momordicae charantiae with described weight proportion, Folium Mori and Rhizoma Polygonati Odorati add water or ethanol extracts, extracting solution is concentrated, dry, make dry extract, be ground into powder, add various conventional adjuvant required when preparing different dosage form, as diluent, disintegrating agent, excipient, binding agent, lubricant, surfactant, filler, antiseptic, stabilizing agent, correctives, thickening agent, fluidizer etc., method of Chinese medicinal with routine is prepared into any peroral dosage form commonly used, as tablet, dispersible tablet, effervescent tablet, oral cavity disintegration tablet, buccal tablet, chewable tablet, capsule, soft capsule, microcapsule, granule, pill, powder, drop pill, slow releasing preparation, controlled release preparation, oral liquid etc.
The preferred for preparation method of Chinese medicine composition of the present invention is as follows:
Fructus Momordicae charantiae with described weight proportion, Folium Mori and Rhizoma Polygonati Odorati add twice of the ethanol extraction of 10 times of amounts and 8 times amount 70%, filter, merging filtrate, reclaim ethanol, be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure, make dry extract, be ground into powder, add various conventional adjuvant required when preparing different dosage form, as diluent, disintegrating agent, excipient, binding agent, lubricant, surfactant, filler, antiseptic, stabilizing agent, correctives, thickening agent, fluidizer etc., method of Chinese medicinal with routine is prepared into any peroral dosage form commonly used, as tablet, dispersible tablet, effervescent tablet, oral cavity disintegration tablet, buccal tablet, chewable tablet, capsule, soft capsule, microcapsule, granule, pill, powder, drop pill, slow releasing preparation, controlled release preparation, oral liquid etc.
The using method of Chinese medicine composition of the present invention (is example with tablet, capsule, granule):
Tablet: oral, every day 2 times, each 3 (every contains crude drug 3.5-8.5g)
Capsule: oral, every day 2 times, each 3 (every contains crude drug 3.5-8.5g)
Granule: oral, every day 2 times, each 1 bag (whenever containing a bag crude drug 10.5-25.5g)
Each drug mechanism is as follows among the present invention:
Fructus Momordicae charantiae: having clears away heart-fire makes eye bright, the effect of QI invigorating antipyretic, and Fructus Momordicae charantiae contains Charantin, Charantin etc., and pharmacological evaluation proves that Fructus Momordicae charantiae has the effect of tangible blood sugar lowering.
Folium Mori: effect with heat-clearing and toxic substances removing, removing heat from blood.Pharmacological research shows that Folium Mori have hypoglycemic activity, and its contained ecdysterone all has blood sugar reducing function to the inductive blood sugar increasing of several different methods, can promote that conversion of glucose is a glycogen, but not change intact animal's blood glucose.
Rhizoma Polygonati Odorati: have yin nourishing, moisturize, relieving restlessness, effect such as quench the thirst, pharmacological research shows that Rhizoma Polygonati Odorati has blood fat reducing and blood glucose effect, and the hyperglycemia that epinephrine is caused has remarkable inhibitory action.
In the present composition, Fructus Momordicae charantiae is less edible in people's diet as the plant of bitterness is arranged, and has wherein contained the trace element of a large amount of diabetes patient's needs; Folium Mori have the effect of clearing away heat and cooling blood, can correct the phenomenon that ubiquitous hyperactivity of fire caused by deficiency of YIN among the diabetes patient or stomach have excess-fire; Rhizoma Polygonati Odorati relieving restlessness, the effect of quenching the thirst can be eliminated the common agitation of diabetes patient, thirsty phenomenon; Three medicines are harmonious and fundamentally regulate diabetes patient's body comprehensively, improve diabetes patient's physical condition, and three flavor medicines all have very clear and definite blood sugar lowering pharmacology effect, can be with diabetes patient's blood glucose regulation to normal level.
In sum, the present composition has that clearing away heat and cooling blood, relieving restlessness quench the thirst, hypoglycemic effect.Can be used for treating diabetes.Can be used for preparing the Chinese medicine and the health product of prevention and treatment diabetes.
The present invention with respect to prior art have determined curative effect, have no side effect, taking convenience, cheap advantage.
Further set forth the beneficial effect of Chinese medicine composition of the present invention by following experiment.
For showing the hypoglycemic effect of the present invention, entrust the specified health food functional check of Ministry of Public Health mechanism the present invention to be carried out the animal experiment of blood sugar regulation to diabetes.Table 1 is the influence of the present invention to alloxan induced hyperglycemia rat blood sugar, and table 2 is the influence of wood invention to alloxan induced hyperglycemia rat post-prandial glycemia, and table 3 is the influence of the present invention to normal rat blood sugar.
Table 1 the present invention is to the influence of alloxan induced hyperglycemia rat blood sugar
* compare p＜0.05 with the hyperglycemia model group
Table 2 the present invention is to the influence of alloxan induced hyperglycemia rat post-prandial glycemia
* p＜0.01 of comparing with the hyperglycemia model group
Table 3 the present invention is to the influence of normal rat blood sugar (X ± SD)
Test initial stage F=0.011, P=0.998; Test F=2.102 in latter stage, P=0.118
Table 1-3 result shows that the present invention does not have influence to normal rat blood sugar.High dose of the present invention has tangible reduction effect to the hyperglycemic rat blood glucose due to the alloxan, and middle and high dosage can improve the carbohydrate tolerance by the caused hyperglycemic rat of alloxan.
The specific embodiment
Embodiment 1:
The preparation of the capsule of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 10kg, Folium Mori 5kg and Rhizoma Polygonati Odorati 6kg, standby;
B) with Fructus Momordicae charantiae, Semen Fagopyri Esculenti and the Folium Mori ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, filter, merge filtrate twice, reclaim ethanol, be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is broken into powder, drying, the snap fit capsule of packing into.
Embodiment 2:
The preparation of the granule of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 30kg, Folium Mori 9kg and Rhizoma Polygonati Odorati 12kg, standby;
B) with Fructus Momordicae charantiae, Semen Fagopyri Esculenti and the Folium Mori ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, merge filtrate twice, reclaim ethanol, be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added ethanol and make adhesive, add appropriate amount of starch and make filler, make granule.
Embodiment 3:
The preparation of the granule of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 20kg, Folium Mori 9kg and Rhizoma Polygonati Odorati 6kg, standby;
B) Fructus Momordicae charantiae, Semen Fagopyri Esculenti and Folium Mori are extracted twice with 10 times of amounts and 8 times of water gagings, merge filtrate twice, be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added ethanol and make adhesive, add appropriate amount of starch and make filler, make granule.
Embodiment 4:
The preparation of the tablet of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 15kg, Folium Mori 7kg and Rhizoma Polygonati Odorati 9kg, standby;
B) with Fructus Momordicae charantiae, Semen Fagopyri Esculenti and the Folium Mori ethanol extraction twice with 10 times of amounts and 8 times of amounts 80%, merge filtrate twice, reclaim ethanol and be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added adjuvant and make granule, and dry, and compacting is in flakes.
Embodiment 5:
The preparation of the tablet of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 20kg, Folium Mori 9kg and Rhizoma Polygonati Odorati 9kg, standby;
B) with Fructus Momordicae charantiae, Semen Fagopyri Esculenti and the Folium Mori ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, merge filtrate twice, reclaim ethanol and be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added adjuvant and make granule, and dry, and compacting is in flakes.
Embodiment 6:
The preparation of the effervescent tablet of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 12kg, Folium Mori 7kg and Rhizoma Polygonati Odorati 6kg, standby;
B) with Fructus Momordicae charantiae, Semen Fagopyri Esculenti and the Folium Mori ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, merge filtrate twice, reclaim ethanol and be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added tartaric acid, sodium bicarbonate, sweeting agent, filler mixing, granulate with dehydrated alcohol, drying adds the lubricant mixing, tabletting, promptly.
Embodiment 7:
The preparation of the dispersible tablet of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 30kg, Folium Mori 7kg and Rhizoma Polygonati Odorati 9kg, standby;
B) with Fructus Momordicae charantiae, Semen Fagopyri Esculenti and the Folium Mori ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, merge filtrate twice, reclaim ethanol and be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added disintegrating agent, filler or diluent, mix homogeneously adds binding agent and makes soft material, the system granule, and drying adds part disintegrating agent, fluidizer or lubricant mixing, tabletting, promptly.
Claims (5)
1, a kind of Chinese medicine composition with hypoglycemic activity is characterized in that, it is to be made by following bulk drugs: Fructus Momordicae charantiae 10-30 part, Folium Mori 5-9 part and Rhizoma Polygonati Odorati 6-12 part.
According to the Chinese medicine composition of claim 1, it is characterized in that 2, it is to be made by following bulk drugs: 9 parts of 15 parts in Fructus Momordicae charantiae, 7 parts on Folium Mori and Rhizoma Polygonati Odorati.
3, the preparation method of claim 1 or 2 described Chinese medicine compositions is characterized in that, this method is:
Fructus Momordicae charantiae, Folium Mori and the Rhizoma Polygonati Odorati of described weight proportion added water or ethanol extracts, extracting solution is concentrated, drying makes dry extract, is ground into powder, is prepared into active component; The gained active component is mixed with adjuvant, make any medicament on the pharmaceutics.
4, the preparation method of Chinese medicine composition according to claim 3 is characterized in that, it comprises the following steps:
Fructus Momordicae charantiae, Folium Mori and the Rhizoma Polygonati Odorati of described weight proportion added 70% ethanol extract 2 times, extracting solution is merged, the concentrating under reduced pressure relative density is measured 1.25-1.30 down for 60 ℃, and drying under reduced pressure makes dry extract, is ground into powder, is prepared into active component; The gained active component is mixed with adjuvant, make any medicament on the pharmaceutics.
5, claim 1 or 2 described Chinese medicine compositions are used to prepare prevention and the medicine of treatment diabetes disease or the application of health food.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101785076A CN101450166A (en) | 2007-11-30 | 2007-11-30 | Traditional Chinese medicine composition with blood-sugar function and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101785076A CN101450166A (en) | 2007-11-30 | 2007-11-30 | Traditional Chinese medicine composition with blood-sugar function and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101450166A true CN101450166A (en) | 2009-06-10 |
Family
ID=40732764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101785076A Pending CN101450166A (en) | 2007-11-30 | 2007-11-30 | Traditional Chinese medicine composition with blood-sugar function and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101450166A (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102224931A (en) * | 2011-06-01 | 2011-10-26 | 四川科伦新光健康药业有限公司 | Composition assisting in reduction of blood sugar |
| CN103301310A (en) * | 2013-05-11 | 2013-09-18 | 刘越泽 | Blood glucose-reducing Chinese medicine preparation and preparation method thereof |
| CN103989938A (en) * | 2014-05-28 | 2014-08-20 | 高益槐 | Chitosan composition for preventing and treating diabetes and preparation method of chitosan composition |
| CN104173734A (en) * | 2013-05-28 | 2014-12-03 | 北京中医药大学 | Pharmaceutical composition for treating impaired glucose regulation and preparation method thereof |
| CN104857088A (en) * | 2015-06-14 | 2015-08-26 | 威海紫光金奥力生物技术有限公司 | Preparation method of mulberry leaf compound capsule for lowering blood glucose in assistant manner |
| CN105194307A (en) * | 2015-09-17 | 2015-12-30 | 上海秋橙新材料科技有限公司 | Blood-sugar-decreasing tea |
| CN105267755A (en) * | 2015-11-19 | 2016-01-27 | 刘庆华 | Blood-glucose-reducing oral liquid |
| CN106605822A (en) * | 2016-12-19 | 2017-05-03 | 西安源森生物科技有限公司 | Composition facilitating reducing of blood sugar and preparation method of composition |
| CN106606529A (en) * | 2016-12-27 | 2017-05-03 | 南京圣诺生物科技实业有限公司 | Composition with auxiliary blood sugar reduction efficacy, and preparation method and application thereof |
| CN106975012A (en) * | 2017-05-18 | 2017-07-25 | 成都中医药大学 | A kind of traditional Chinese medicinal composition with effect of reducing blood sugar and preparation method thereof |
| CN107625129A (en) * | 2017-09-06 | 2018-01-26 | 如皋市滋生堂生物科技有限公司 | A kind of hypoglycemic and the health food and its production method of reducing blood lipid |
| CN108771717A (en) * | 2018-09-11 | 2018-11-09 | 山西中医药大学 | A kind of hypoglycemic health drink, preparation method and application |
| CN109394970A (en) * | 2019-01-14 | 2019-03-01 | 楚雄州百草岭药业发展有限公司 | A kind of mulberry leaf composition and preparation method thereof, preparation and application |
| CN110251655A (en) * | 2019-07-31 | 2019-09-20 | 张先奇 | A kind of pharmaceutical composition and preparation method thereof for treating diabetes |
| CN111821380A (en) * | 2020-07-31 | 2020-10-27 | 深圳市清生元生物技术股份有限公司 | Hypoglycemic composition and preparation method and application thereof |
-
2007
- 2007-11-30 CN CNA2007101785076A patent/CN101450166A/en active Pending
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102224931B (en) * | 2011-06-01 | 2013-03-06 | 四川科伦新光健康药业有限公司 | Composition assisting in reduction of blood sugar |
| CN102224931A (en) * | 2011-06-01 | 2011-10-26 | 四川科伦新光健康药业有限公司 | Composition assisting in reduction of blood sugar |
| CN103301310A (en) * | 2013-05-11 | 2013-09-18 | 刘越泽 | Blood glucose-reducing Chinese medicine preparation and preparation method thereof |
| CN104173734B (en) * | 2013-05-28 | 2017-11-10 | 北京中医药大学 | A kind of pharmaceutical composition for treating IGR and preparation method thereof |
| CN104173734A (en) * | 2013-05-28 | 2014-12-03 | 北京中医药大学 | Pharmaceutical composition for treating impaired glucose regulation and preparation method thereof |
| CN103989938A (en) * | 2014-05-28 | 2014-08-20 | 高益槐 | Chitosan composition for preventing and treating diabetes and preparation method of chitosan composition |
| CN104857088A (en) * | 2015-06-14 | 2015-08-26 | 威海紫光金奥力生物技术有限公司 | Preparation method of mulberry leaf compound capsule for lowering blood glucose in assistant manner |
| CN105194307A (en) * | 2015-09-17 | 2015-12-30 | 上海秋橙新材料科技有限公司 | Blood-sugar-decreasing tea |
| CN105267755A (en) * | 2015-11-19 | 2016-01-27 | 刘庆华 | Blood-glucose-reducing oral liquid |
| CN106605822A (en) * | 2016-12-19 | 2017-05-03 | 西安源森生物科技有限公司 | Composition facilitating reducing of blood sugar and preparation method of composition |
| CN106606529A (en) * | 2016-12-27 | 2017-05-03 | 南京圣诺生物科技实业有限公司 | Composition with auxiliary blood sugar reduction efficacy, and preparation method and application thereof |
| CN106975012A (en) * | 2017-05-18 | 2017-07-25 | 成都中医药大学 | A kind of traditional Chinese medicinal composition with effect of reducing blood sugar and preparation method thereof |
| CN107625129A (en) * | 2017-09-06 | 2018-01-26 | 如皋市滋生堂生物科技有限公司 | A kind of hypoglycemic and the health food and its production method of reducing blood lipid |
| CN108771717A (en) * | 2018-09-11 | 2018-11-09 | 山西中医药大学 | A kind of hypoglycemic health drink, preparation method and application |
| CN109394970A (en) * | 2019-01-14 | 2019-03-01 | 楚雄州百草岭药业发展有限公司 | A kind of mulberry leaf composition and preparation method thereof, preparation and application |
| CN110251655A (en) * | 2019-07-31 | 2019-09-20 | 张先奇 | A kind of pharmaceutical composition and preparation method thereof for treating diabetes |
| CN111821380A (en) * | 2020-07-31 | 2020-10-27 | 深圳市清生元生物技术股份有限公司 | Hypoglycemic composition and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101450166A (en) | Traditional Chinese medicine composition with blood-sugar function and preparation method thereof | |
| CN101450095A (en) | Medicine composition with blood-sugar reduction function and preparation method thereof | |
| CN103948786B (en) | Traditional Chinese medicine for treating diabetes | |
| CN101856405B (en) | A kind of pharmaceutical composition for treating type 2 diabetes and its preparation method | |
| CN101450101A (en) | Medicine composition with blood-sugar reduction function and preparation method thereof | |
| CN101085039B (en) | Composition for preventing and treating diabetes (hyperglycaemia) and its preparation method | |
| CN1939506B (en) | Preparation with blood-pressure, blood-sugar and blood-fat lowering functions and its making method | |
| CN101450177A (en) | Traditional Chinese medicine composition with blood sugar reducing function and preparation method thereof | |
| CN101433597A (en) | Chinese medicinal composition with function for reducing blood sugar and preparation method thereof | |
| CN101433667A (en) | Pharmaceutical composition with function for reducing blood sugar and preparation method thereof | |
| CN101450162A (en) | Traditional Chinese medicine composition with blood-sugar reduction function and preparation method thereof | |
| CN101491605A (en) | Combination with blood sugar reducing function and preparation method thereof | |
| CN102743646B (en) | Medicinal composition for inspecting and preventing diabetes | |
| CN1329049C (en) | Blood sugar- and blood pressure-lowering medicine | |
| CN101491668B (en) | Composition with blood-sugar reducing function and preparation method thereof | |
| CN101450174A (en) | Medicine composition with blood-sugar reduction function and preparation method thereof | |
| CN105125885B (en) | It is a kind of to be used to prevent Chinese medicine composition of diabetes and preparation method thereof | |
| CN102742830B (en) | Dietetic therapy product for regulating blood sugar and preparation method thereof | |
| CN101450096A (en) | Medicine composition with blood-sugar reduction function and preparation method thereof | |
| CN101757114A (en) | Hypoglycemic product and preparation method thereof | |
| CN101491581A (en) | Combination with blood sugar reducing function and preparation method thereof | |
| CN105535070A (en) | Medicine composition for treating diabetes and preparation method and application thereof | |
| CN101491580A (en) | Combination with blood sugar reducing function and preparation method thereof | |
| CN103989940A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN102908508B (en) | Medicinal composition for treating seborrheic alopecia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090610 |